We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

24 hedge funds and large institutions have $3.62M invested in Abeona Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

19.49% more ownership

Funds ownership: 0.57% → 20.06% (+19%)

23% less capital invested

Capital invested by funds: $4.68M → $3.62M (-$1.07M)

43% less funds holding

Funds holding: 42 → 24 (-18)

75% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 12

77% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 22

Holders
24
Holders Change
-18
Holders Change %
-42.86%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
12
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$832K
2
ACM
AIGH Capital Management
Maryland
+$580K
3
CT
Cambridge Trust
Massachusetts
+$258K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$140K
5
WVP
Worth Venture Partners
New Jersey
+$138K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$256K
2
Renaissance Technologies
Renaissance Technologies
New York
-$115K
3
Millennium Management
Millennium Management
New York
-$46K
4
Northern Trust
Northern Trust
Illinois
-$38K
5
KPW
Kore Private Wealth
New York
-$32K
Name Holding Trade Value Shares
Change 		Change in
Stake
KPW
26
Kore Private Wealth
New York
– -$32K -6,185 Closed
WM
27
WS Management
Florida
– -$19K -3,696 Closed
CBFP
28
Cedar Brook Financial Partners
Ohio
– -$11K -2,200 Closed
SC
29
Shay Capital
New York
– -$10K -2,000 Closed
UBS Group
30
UBS Group
Switzerland
– -$9K -1,773 Closed
Bank of New York Mellon
31
Bank of New York Mellon
New York
– -$9K -1,763 Closed
MHS
32
M Holdings Securities
Oregon
– -$8K -1,472 Closed
Jane Street
33
Jane Street
New York
– -$7K -1,297 Closed
EGM
34
Engineers Gate Manager
New York
– -$5K -895 Closed
SW
35
SVB Wealth
Massachusetts
– -$4K -780 Closed
Victory Capital Management
36
Victory Capital Management
Texas
– -$4K -760 Closed
WA
37
WealthTrust Axiom
Pennsylvania
– -$3K -760 Closed
Squarepoint
38
Squarepoint
New York
– -$3K -568 Closed
Two Sigma Advisers
39
Two Sigma Advisers
New York
– -$3K -552 Closed
MML Investors Services
40
MML Investors Services
Massachusetts
– -$2K -400 Closed
Wells Fargo
41
Wells Fargo
California
– -$16 -4 -10%
GRP
42
Global Retirement Partners
California
– +$25 +6 New
1
2

ABEO Hedge Fund Activity: Q3 2022 in Review

24 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2022, worth a combined $3.62M — down 23% from $4.68M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ABEO and 5 opened new positions — a net loss of 17 holders — while 12 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $832K. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $256K sold.

  • 24 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2022, down from 42 in Q2 2022.
  • Funds reported $3.62M of Abeona Therapeutics stock for Q3 2022, down 23% quarter-over-quarter.
  • 5 funds opened new Abeona Therapeutics positions in Q3 2022 and 22 closed out, a net change of -17 holders.
  • The largest Abeona Therapeutics buyer in Q3 2022 was Vanguard Group, an estimated $832K added.
  • The largest Abeona Therapeutics seller in Q3 2022 was D.E. Shaw & Co, an estimated $256K sold.

Based on aggregated 13F filings for Q3 2022.